Search Results 261-270 of 17304 for Proto-oncogene
Rodriguez-Bravo, studies cell and molecular biology mechanisms of genome organization and stability regulation in cancer. The lab has a special interest in ...
Dr. Kaufmann and his team in the Anticancer Drug Action Lab at Mayo Clinic are studying cellular responses to DNA damage induced by topoisomerase poisons.
This project will investigate whether ctDNA analysis in newly diagnosed stage I, II, III breast cancer patients treated with neoadjuvant systemic therapy can ...
Cobomarsen is designed to inhibit the activity of a molecule called miR-155 that may be important to the growth and survival of MF cancer cells. The study will ...
Learn about symptoms, diagnosis and treatment of these growths that occur in and around the ovaries and fallopian tubes.
Latest stories · New study finds triple-negative breast cancer tumors with an increase in immune cells have · Could CAR-T cell therapy improve kidney transplants?
The field of pharmacogenomics, or pharmacogenetics, helps to determine if your body activates certain medications. These tests look for changes or variants ...
Videos highlight how the Bioinformatics Core at Mayo Clinic supports research in Mayo Clinic Comprehensive Cancer Center and Mayo Clinic's Center for ...
However, the presence of oncogenic signaling (Kras mutations, EGF-R) can push these duct cells to develop lesions that are at risk for tumor development. To ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.